-
Making Cell and Gene Therapy Affordable
Suzanne Elvidge
November 04, 2024
Cell and gene therapies (CGTs) have revolutionised medicine, providing personalised and targeted treatment for life-limiting diseases from genetic disorders to hard-to-treat cance.However, these cutting-edge therapeutics can come with a high price tag.
-
How to Find and Select the Right Products and Partners
Suzanne Elvidge
October 15, 2024
Working in partnership, is a powerful way to boost pipelines and support preclinical and clinical research and development.The challenge is finding the right partner and the right product or project.
-
Hints and Tips for Negotiating and Managing National and International Deals
Suzanne Elvidge
October 15, 2024
Once a company has made the decision to partner or collaborate and has found the right product or the right partner – the next step is to create a strong relationship and negotiate the best possible deal for both parties.
-
Working Collaboratively: Using Co-operation to Boost Pipelines
Suzanne Elvidge
September 26, 2024
As drugs, devices and other healthcare products become more innovative and complex, and as development costs increase, working collaboratively becomes more important.
-
The Importance of Patient-Centricity in Drug Development
Suzanne Elvidge
August 29, 2024
Patient centricity can be defined as: ‘Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family.
-
Immunoconjugates: Biological Missiles for Diagnosis and Treatment
Suzanne Elvidge
August 02, 2024
Immunoconjugates already play an important role in the treatment of cancer, and their role is likely to expand into other therapeutic indications.
-
New Drugs for Old: Repurposing and Repositioning Pharmaceuticals
Suzanne Elvidge
July 15, 2024
Drug repurposing and repositioning offers a cost effective and efficient route to the market that allows patients to get access to drugs more quickly.
-
The Future of Obesity Drugs
Suzanne Elvidge
July 01, 2024
By the year 2030, over a billion people could be affected by obesity, according to the World Obesity Forum.The obesity drug market value is expected to reach around $37.1 billion in 2031.
-
Drug delivery on the go: Wearable delivery systems
Suzanne Elvidge
July 03, 2024
Wearable drug delivery systems, also known as on-body systems, are designed to accurately deliver the right dose of a drug to the right place at the right time, via a pump and cannula or needle, or a drug delivery patch.
-
Microelectromechanical systems (MEMS) in drug delivery
Suzanne Elvidge
May 17, 2024
Drug delivery is about improving the efficacy and safety of therapeutics by getting the right dose of the right drug to the right place at the right rate and time.